John Pinney



John Pinney has spent 45 years in the fields of disease prevention, substance abuse, health policy, and pharmaceutical consulting. His experience includes a wide range of executive positions in government, nonprofit, and academic organizations.

John has consulted on numerous major Rx-to-OTC switch, drug development, issues management and product stewardship projects in support of consumer and prescription companies. 

In 1994, he founded PinneyAssociates to focus on consulting to the pharmaceutical industry, bringing a wealth of experience at the intersection of policy, science and regulation to developing and implementing solutions to complex regulatory challenges and public health problems.

Michael R Hufford, PhD


Michael Hufford, PhD has spent 20 years as an entrepreneur, co-founding multiple pharmaceutical, medical device, and mobile health companies across a wide range of therapeutic areas. He has raised money from both public and private markets, including VCs and angel investors.

He has led pharmaceutical development teams through FDA approvals, as well as supporting Rx-to-OTC switches.

An addiction researcher by training, he received his PhD from the University of Pittsburgh and completed a Clinical and Research Fellowship in the Department of Psychiatry at Harvard Medical School.